Vancouver’s Derm-Biome Pharmaceuticals has announced a collaboration with Dr. Anna Mandinova from the Department of Dermatology at Massachusetts General Hospital in a skin cancer study. Derm-Biome is a preclinical biopharmaceutical company dedicated to improving skin health. They have topical lead compounds for inflammatory skin diseases (acne and atopic dermatitis) and precancerous skin conditions/non-melanoma skin cancers […]